The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to price negotiation under the Inflation Reduction Act of 2023 (IRA) and the Act’s potential impact on profits. But an even bigger force… Continue Reading
Mental health conditions can take a staggering toll on an individual physically, socially and financially. Many patients languish with partially effective or ineffective treatments, even though new options are constantly entering the market. At OM1, we are using our… Continue Reading
The healthcare industry — from providers and health systems to payers — is increasingly adopting value-based care practices, which is not surprising given that approximately 61% of all healthcare payments are tied to value and quality in some way. In… Continue Reading
Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason Drenning, PhD, Chief Commercial Officer of STATinMED Research sat down with HealthEconomics.Com to discuss the data landscape, industry trends and… Continue Reading
Interview with Dr. Kevin Haynes, Principal Scientist, HealthCore-NERI. Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Kevin Haynes, Principal Scientist at HealthCore-NERI, to discuss closing gaps in real-world evidence through data linkage. The mission of HealthCore-NERI is to… Continue Reading
